Newsbenzinga
FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches
· Published
Article summary
FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk claims after scientific review.
An excerpt from the original article.
Comments —
Loading comments…